Amarin | AMRN - Assets

Stock Price
15.66
Daily Change
0.03 0.19%
Monthly
0.71%
Yearly
35.42%
Q1 Forecast
15.11

Amarin reported $659.81M in Assets for its fiscal quarter ending in September of 2025.





Assets Change Date
AbbVie USD 133.96B 62M Dec/2025
Alnylam Pharmaceuticals USD 4.97B 114.67M Dec/2025
Amarin USD 659.81M 10.31M Sep/2025
AstraZeneca USD 114.07B 382M Dec/2025
BioCryst Pharmaceuticals USD 446.42M 10.76M Sep/2025
DBV Technologies USD 110.49M 32.93M Sep/2025
Esperion Therapeutics USD 364.02M 16.93M Sep/2025
GlaxoSmithKline GBP 61.12B 221M Dec/2025
Halozyme Therapeutics USD 2.53B 304.09M Dec/2025
Heron Therapeutics USD 248.95M 16.86M Sep/2025
Ionis Pharmaceuticals USD 3.03B 47.96M Sep/2025
Nektar Therapeutics USD 301.35M 93.81M Sep/2025
Neurocrine Biosciences USD 4.63B 365.8M Dec/2025
Novartis USD 107.29B 2.89B Sep/2025